Companies / Intercept Pharmaceuticals, Inc.
Intercept Pharmaceuticals, Inc.
ICPTCIK 1270073
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Nov 8, 2023 | Akkaraju Srinivas Director | Other Shares tendered | Common Stock | $12.17M | -641K -100.00% | 0 | low |
| Nov 8, 2023 | Pruzanski Mark Director | Other Shares tendered | Common Stock | $11.76M | -619K -100.00% | 0 | low |
| Mar 12, 2021 | Akkaraju Srinivas Director | Buy Open-market buy | Common Stock | $3.13M | +147K +29.78% | 640,688 | high |
| Nov 8, 2023 | Durso Jerome Benedict CEO | Other Sold to issuer | Common Stock | $1.95M | -103K -100.00% | 0 | low |
| Mar 10, 2021 | Akkaraju Srinivas Director | Buy Open-market buy | Common Stock | $1.53M | +73K +18.19% | 477,129 | high |
| Dec 31, 2020 | Pruzanski Mark Director | Grant Grant or award | Common Stock | $1.02M | +41K +8.67% | 516,753 | low |
| Nov 8, 2023 | Durso Jerome Benedict CEO | Other Shares tendered | Common Stock | $984.5K | -52K -100.00% | 0 | low |
| Nov 8, 2023 | Berrey M Michelle Executive | Other Sold to issuer | Common Stock | $984.0K | -52K -100.00% | 0 | low |